Latest Nephros Inc. (NEPH) Headlines MSC Crui
Post# of 15
Posted On: 03/10/2014 6:35:13 PM
Latest Nephros Inc. (NEPH) Headlines
MSC Cruises' Easter Spring Fling on MSC Divina
PR Newswire - Tue Mar 04, 8:59AM CST
Looking for a family getaway this Easter? Look no further. MSC Cruises, the only cruise line in which kids sail free year-round, is offering not only special rates but a full week of Easter fun for kids and parents alike.
Nephros and Bellco Extend and Expand License Agreement
PR Newswire - Tue Feb 25, 4:53PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Bellco S.r.l., an Italy-based company focused on Dialysis and Extracorporeal Blood Purification, announced today that the companies have signed an amendment to their existing license agreement.
Nephros Announces Rights Offering
PR Newswire - Wed Feb 12, 5:00PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today that it has commenced its previously disclosed rights offering. On February 12, 2014, the Company will distribute to holders of its common stock and/or warrants one non-transferable subscription right for each share of common stock, and each share of common stock underlying a warrant, held as of January 30, 2014. The rights offering will expire at 5:00 p.m., Eastern Time, on March 14, 2014, if not extended by the Company in its sole discretion.
Nephros names Daron Evans to board
M2 - Mon Dec 02, 6:26AM CST
Nephros Inc (OTCBB:NEPH), a commercial stage medical device company offering liquid purification ultrafilters, announced on Friday that it has appointed Daron Evans to its board of directors.
Nephros Appoints Daron Evans to Board of Directors
PR Newswire - Fri Nov 29, 4:00PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today the appointment of Daron Evans to its Board of Directors. Mr. Evans replaces James S. Scibetta who will be leaving the Board effective December 31, 2013. Mr. Evans was also named a member of the Audit Committee.
Nephros Reports Third Quarter 2013 Financial Results and Completes Bridge Financing
PR Newswire - Thu Nov 14, 4:00PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three and nine months ended September 30th 2013 and that the company entered into a bridge loan and security agreement with Lambda Investors LLC, an affiliate of Wexford Capital LP and the company's largest shareholder.
Nephros Reports Second Quarter 2013 Financial Results
PR Newswire - Tue Aug 13, 3:46PM CDT
Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced financial results for the three and six months ended June 30, 2013.
Nephros Announces Completion of Rights Offering
PR Newswire - Thu May 23, 3:30PM CDT
Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today the successful completion of its rights offering. In addition, the concurrent temporary reduction in exercise price for the company's March 2011 warrants expired on May 17, 2013.
Nephros Reports First Quarter 2013 Financial Results
PR Newswire - Wed May 08, 3:15PM CDT
Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three months ended March 31, 2013.
Nephros Inc's ultrafilters to be distributed by Chem-Aqua Inc in North America
M2 - Tue Feb 05, 8:34AM CST
Nephros Inc (OTC BB:NEPH) said on Monday that it has entered into a non-exclusive distributor agreement to distribute its innovative ultrafilters in North America.
Nephros and Chem-Aqua Announce Distribution Agreement
PR Newswire - Mon Feb 04, 3:45PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH) and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America. Chem-Aqua is now beginning launch efforts, including scheduling training sessions and promoting ultrafilters to the hospital market.
Nephros Completes Bridge Financing
PR Newswire - Mon Feb 04, 3:32PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that the company has entered into a bridge loan and security agreement with Lambda Investors LLC, an affiliate of Wexford Capital LP and the company's largest shareholder.
Nephros Receives EUR 600,000 Payment from Bellco S.r.l.
PR Newswire - Tue Jan 15, 3:30PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced that on January 15, 2013, Nephros received the scheduled payment of EUR 600,000 from Bellco S.r.l. under the previously announced license agreement.
MSC Cruises' Easter Spring Fling on MSC Divina
PR Newswire - Tue Mar 04, 8:59AM CST
Looking for a family getaway this Easter? Look no further. MSC Cruises, the only cruise line in which kids sail free year-round, is offering not only special rates but a full week of Easter fun for kids and parents alike.
Nephros and Bellco Extend and Expand License Agreement
PR Newswire - Tue Feb 25, 4:53PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and Bellco S.r.l., an Italy-based company focused on Dialysis and Extracorporeal Blood Purification, announced today that the companies have signed an amendment to their existing license agreement.
Nephros Announces Rights Offering
PR Newswire - Wed Feb 12, 5:00PM CST
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today that it has commenced its previously disclosed rights offering. On February 12, 2014, the Company will distribute to holders of its common stock and/or warrants one non-transferable subscription right for each share of common stock, and each share of common stock underlying a warrant, held as of January 30, 2014. The rights offering will expire at 5:00 p.m., Eastern Time, on March 14, 2014, if not extended by the Company in its sole discretion.
Nephros names Daron Evans to board
M2 - Mon Dec 02, 6:26AM CST
Nephros Inc (OTCBB:NEPH), a commercial stage medical device company offering liquid purification ultrafilters, announced on Friday that it has appointed Daron Evans to its board of directors.
Nephros Appoints Daron Evans to Board of Directors
PR Newswire - Fri Nov 29, 4:00PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today the appointment of Daron Evans to its Board of Directors. Mr. Evans replaces James S. Scibetta who will be leaving the Board effective December 31, 2013. Mr. Evans was also named a member of the Audit Committee.
Nephros Reports Third Quarter 2013 Financial Results and Completes Bridge Financing
PR Newswire - Thu Nov 14, 4:00PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three and nine months ended September 30th 2013 and that the company entered into a bridge loan and security agreement with Lambda Investors LLC, an affiliate of Wexford Capital LP and the company's largest shareholder.
Nephros Reports Second Quarter 2013 Financial Results
PR Newswire - Tue Aug 13, 3:46PM CDT
Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced financial results for the three and six months ended June 30, 2013.
Nephros Announces Completion of Rights Offering
PR Newswire - Thu May 23, 3:30PM CDT
Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today the successful completion of its rights offering. In addition, the concurrent temporary reduction in exercise price for the company's March 2011 warrants expired on May 17, 2013.
Nephros Reports First Quarter 2013 Financial Results
PR Newswire - Wed May 08, 3:15PM CDT
Nephros, Inc. (OTC Bulletin Board:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today financial results for the three months ended March 31, 2013.
Nephros Inc's ultrafilters to be distributed by Chem-Aqua Inc in North America
M2 - Tue Feb 05, 8:34AM CST
Nephros Inc (OTC BB:NEPH) said on Monday that it has entered into a non-exclusive distributor agreement to distribute its innovative ultrafilters in North America.
Nephros and Chem-Aqua Announce Distribution Agreement
PR Newswire - Mon Feb 04, 3:45PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH) and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America. Chem-Aqua is now beginning launch efforts, including scheduling training sessions and promoting ultrafilters to the hospital market.
Nephros Completes Bridge Financing
PR Newswire - Mon Feb 04, 3:32PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that the company has entered into a bridge loan and security agreement with Lambda Investors LLC, an affiliate of Wexford Capital LP and the company's largest shareholder.
Nephros Receives EUR 600,000 Payment from Bellco S.r.l.
PR Newswire - Tue Jan 15, 3:30PM CST
Nephros, Inc. (OTC Bulletin Board: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced that on January 15, 2013, Nephros received the scheduled payment of EUR 600,000 from Bellco S.r.l. under the previously announced license agreement.
(0)
(0)